Abdominal aortic aneurysm as a complex multifactorial disease: Interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 117-132

  Pearce, William H ^a   Shively, Vera P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aneurysm; Inflammation; Metalloproteinases; MMPs; Polymorphisms

Indexed keywords

ARRESTEN; CANSTATIN; CHEMOKINE; CYTOKINE; DALTEPARIN; ELASTIN; ENDOREPELLIN; ENDOSTATIN; GELATINASE A; GELATINASE B; GROWTH FACTOR; LEUKOCYTE ANTIGEN; MATRIX METALLOPROTEINASE; MEMBRANE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN; AUTACOID;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BYSTANDER EFFECT; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; GENETIC RISK; HOMEOSTASIS; HUMAN; INFECTION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; POPULATION SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; REVIEW;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; AUTOIMMUNITY; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; POLYMORPHISM, GENETIC;

EID: 34249848165     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.025     Document Type: Conference Paper

References (53)

1. GROSS, J. & C.M. LAPIERE. 1962. Collagenolytic activity in amphibian tissue: a tissue culture assay. Proc. Natl. Acad. Sci. USA 48: 1014-1022.
2. BRINCKERHOFF, C.E. & L.M. MATRISIAN. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3: 207-214.
3. VAN DEN STEEN, P.E., B. DUBOIS, I. NELISSEN, et al. 2002. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37: 375-536.
4. KUZUYA, M. & A. IGUCHI. 2003. Role of matrix metalloproteinases in vascular remodeling. J. Atheroscler. Thromb. 10: 275-282.
5. LEE, M.H. & G. MURPHY. 2004. Matrix metalloproteinases at a glance. J. Cell. Sci. 117: 4015-4016.
6. STAMENKOVIC, I. 2003. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200: 448-464.
7. SOMERVILLE, R.P., S.A. OBLANDER & S.S. APTE. 2003. Matrix metalloproteinases old dogs with new tricks. Genome Biol. 4: 216.1-216.11.
8. SINHA, I., K.K. HANNAWA, J.L. ELIASON, et al. 2004. Early MT-1 MMP expression following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms. Surgery 136: 176-182.
9. MOTT, J.D. & Z. WERB. 2004. Regulation of matrix biology by matrix metalloproteinases. Cur. Opin. Cell. Biol. 16: 558-564.
10. MANNELLO, F., F. LUCHETTI, E. FALCIERI, et al. 2005. Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis 10: 19-24.
11. VANWART, H.E. & H. BIRKEDAL- HANSEN. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to entire metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-582.
12. MARTIGNETTI, J.A., A.A. AQEEL, W. AL SEWAIRI, et al. 2001. Mutation of the matrix metalloproteinases 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Gen. 28: 261-265.
13. NAKAHARA, H., L. HOWARD, E.W. THOMPSON, et al. 1997. Transmembrane/cytoplastmic domain-mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion. Proceedings of the National Academy of Science of the United States of America. 94: 7959-7964.
14. YE, S. 2000. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 19: 623-629.
15. BUSUTTIL, R.W., A.M. ABOU-ZAMZAM & H.I. MACHLEDER. 1980. Collagenase activity of the human aorta.Acomparison of patients with and without abdominal aortic aneurysms. Arch. Surg. 115: 1373-1378.
16. LONGO, G.M., S.J. BUDA, N. FIOTTA, et al. 2005. MMP-12 has a role in abdominal aortic aneurysms in mice. Surgery 137: 457-462.
17. WASSEF, M., B.T. BAXTER, R.L. CHISHOLM, et al. 2001. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J. Vasc. Surg. 34: 730-738.
18. PYO, R., J.K. LEE, J.M. SHIPLEY, et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
19. MAO, D., J.K. LEE, S.J. VANVICKLE, et al. 1999. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem. Biophys. Res. Com. 261: 904-910.
20. LONGO, G.M., W. XIONG, T.C. GREINER, et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110(5): 625-632.
21. FATINI, C., G. PRATESI, F. SOFI, et al. 2005. ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 29: 227-232.
22. HAMANO, K., I. OHISHI, M. UEDA, et al. 1999. Deletion polymorphism in gene for ACE is not a risk factor predisposing to abdominal aortic aneurysm. Eur. J. Vasc. Enodvasc. Surg. 18: 158-161.
23. POLA, R., E. GAETANI, A. SANTOLIQUIDO, et al. 2001. Abdominal aortic aneurysm in normotensive patients: association with ACE gene polymorphism. Eur. J. Vasc. Endovasc. Surg. 21: 445-449.
24. BOWN, M.J., T. HORSBURGH, M.L. NICHOLSON, et al. 2003. Cytokine gene polymorphisms and the inflammatory response to abdominal aortic aneurysm repair. Br. J. Surg. 90(9): 1085-1092.
25. PARKS, W.C. 2002. A confederacy of proteinases. J. Clin. Invest. 110: 613-614.
26. NEPTUNE, E.R., P.A. FRISCHMEYER, D.E. ARKING, et al. 2003. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat. Gen. 33: 407-411.
27. ELKINGTON, P.T.G., C.M. KANE & J.S. FRIEDLAND. 2005. The paradox of matrix metalloproteinases in infectious disease. Clin. Exper. Immunol. 142: 12-20.
28. PARKS, W.C., C.L. WILSON & Y.S. LOPEZ-BOADO. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4: 617-629.
29. NATHAN, C. 2002. Points of control in inflammation. Nature 420: 846-852.
30. NENAN, S., E. BOICHOT, V. LAGENTE, et al. 2005. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem. Inst. Oswaldo Cruz 100(Suppl 1): 167-172.
31. MARIAN, A.J. 2001. On genetics, inflammation, and abdominal aortic aneurysm: can single nucleotide polymorphisms predict the outcome? Circulation 103: 2222-2224.
32. MARIAN, A.J. & E. BOERWINKLE. 2002. "Into Thin Air" and the genetics of complex traits. Circulation 106: 768-769.
33. SHOENFELD, Y. & G. ZANDMAN-GODDARD. 2003. Autoimmune Diseases - The Enemy from Within. First edition. Bio-Rad Laboratories. USA.
34. GREGORY, A.K., N.X. YIN, J. CAPELLA, et al. 1996. Features of autoimmunity in the abdominal aortic aneurysm. Arch. Surg. 131: 85-88.
35. LAHITA, R.G., N. CHIORAZZI & W.H. REEVES, Eds.: 2000. Textbook of the Autoimmune Diseases. Lippincott Williams & Wilkins. Philadelphia.
36. OZSVATH, K.J., H. HIROSE, S. XIA, et al. 1997. Molecular mimicry in human aortic aneurysmal diseases. Ann. N. Y. Acad. Sci. 800: 288-293.
37. SARVETNICK, N. 2000. Etiology of autoimmunity. Immunol. Res. 21/2-3: 357-362.
38. RASMUSSEN, T.E., J.W. HALLETT, R.L. MATHIEU METZGER, et al. 1997. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J. Vasc. Surg. 25: 356-364.
39. RASMUSSEN, T.E., J.W. HALLETT, S. SCHULTE, et al. 2001. Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes. J. Vasc. Surg. 34: 84-89.
40. RASMUSSEN, T.E., J.W. HALLETT, H.D. TAZELAAR, et al. 2002. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J. Vasc. Surg. 35: 988-993.
41. HIROSE, H., M. TAKAGI, N. MIYAGAWA, et al. 1998. Genetic risk factor for abdominal aortic aneurysm: HLA-DR2(15), a Japanese study. J. Vasc. Surg. 7: 500-503.
42. SUGIMOTO, T., M. SADA & H. YAO. 2003. Genetic analysis on HLA loci in Japanese patients with abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 26: 215-218.
43. MONUX, G., F.J. SERRANO, P. VIGIL & E.G. DE LA CONCHA. 2003. Role of HLA-DR in the pathogenesis of abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 26: 211-214.
44. HAUG, E.S., J.F. SKOMSVOLL, G. JACOBSEN, et al. 2003. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J. Vasc. Surg. 38: 492-497.
45. LACROIX-DESMAZES, S., L. MOUTHON, S.V. KAVERI, et al. 1999. Stability of natural self-reactive antibody repertoires during aging. J. Clin. Immunol. 19: 26-34.
46. TOMER, Y. & Y. SHOENFELD. 1998. Review: ageing and autoantibodies. Autoimmunity 1: 141-149.
47. FATINI, C., G. PRATESI, F. SOFI, et al. 2005. ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 29: 227-232.
48. HAMANO, K., I. OHISHI, M. UEDA, et al. 1999. Deletion polymorphism in gene for angiotensin converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 18: 158-161.
49. POLA, R., E. GAETANI, A. SANTOLIQUIDO, et al. 2001. Abdominal aortic aneurysm in normotensive patients: association with ACE gene polymorphism. Eur. J. Vasc. Endovasc. Surg. 21: 445-449.
50. BOWN, M.J., P.R. BURTON, T. HORSBURGH, et al. 2003. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a casecontrol study. J. Vasc. Surg. 37: 999-1005.
51. BOWN, M.J., T. HORSBURGH, M.L. NICHOLSON, et al. 2004. Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair. Eur. J. Vasc. Endovasc. Surg. 28: 274-280.
52. JONES, K.G., D.J. BRULL & L.C. BROWN. 2001. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103: 2260-2265.
53. GHILARDI, G., M.L. BIONDI, L. BATTAGLIOLI, et al. 2004. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Δ32 deletion. J. Vasc. Surg. 40: 995-1000.